rs63749004
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000287.4(PEX6):c.802_815delGACGGACTGGCGCT(p.Asp268CysfsTer8) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000821 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. D268D) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000287.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 4A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health
- peroxisome biogenesis disorder 4BInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Heimler syndrome 2Inheritance: AR Classification: MODERATE Submitted by: G2P
- autosomal recessive cerebellar ataxia-blindness-deafness syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX6 | NM_000287.4 | c.802_815delGACGGACTGGCGCT | p.Asp268CysfsTer8 | frameshift_variant | Exon 1 of 17 | ENST00000304611.13 | NP_000278.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX6 | ENST00000304611.13 | c.802_815delGACGGACTGGCGCT | p.Asp268CysfsTer8 | frameshift_variant | Exon 1 of 17 | 1 | NM_000287.4 | ENSP00000303511.8 | ||
PEX6 | ENST00000244546.4 | c.802_815delGACGGACTGGCGCT | p.Asp268CysfsTer8 | frameshift_variant | Exon 1 of 15 | 1 | ENSP00000244546.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251468 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461890Hom.: 0 AF XY: 0.00000688 AC XY: 5AN XY: 727246 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder Pathogenic:2
Variant summary: PEX6 c.802_815del14 (p.Asp268CysfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay. However, the sequencing of RT-PCR products showed two different transcripts corresponding to the loss of terminal sequence of exon 1, c.226_882 and c.619_882 (p.[Val207_Gln294del, Val76_Gln294del]). The variant allele was found at a frequency of 1.2e-05 in 251468 control chromosomes. c.802_815del14 has been reported as a heterozygous and homozygous phenotype in the literature in multiple individuals affected with Zellweger Syndrome (Levesque_2012 and Matsumoto_2001). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence indicating that homozygous mutant fibroblasts did not produce detectable amounts of either full-length of truncated PEX6 protein and found a severe decrease in peroxisome number, abnomally enlarged peroxisomes and absent matrix protein import into the organelle in the patient compared to control fibroblasts. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
For these reasons, this variant has been classified as Pathogenic. Studies have shown that this premature translational stop signal is associated with altered splicing resulting in multiple RNA products (PMID: 22894767). ClinVar contains an entry for this variant (Variation ID: 555443). This variant is also known as PEX6del619–882. This premature translational stop signal has been observed in individuals with Zellweger spectrum disorder (PMID: 11355018, 22894767). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs63749004, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Asp268Cysfs*8) in the PEX6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX6 are known to be pathogenic (PMID: 10408779, 21031596, 31831025). -
Peroxisome biogenesis disorder 4A (Zellweger);C3553937:Peroxisome biogenesis disorder 4B Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Peroxisome biogenesis disorder 4A (Zellweger);C3553937:Peroxisome biogenesis disorder 4B;C4225267:Heimler syndrome 2 Pathogenic:1
- -
Heimler syndrome 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at